Shin-ichi Mochizuki - Concepedia

Concepedia

Author

Shin-ichi Mochizuki

Megmilk Snow Brand (Japan)

Also Known As

S MOCHIZUKI, S. Mochizuki, S.-I Mochizuki, S.-I. Mochizuki, Shin-Ichi Mochizuki, Shin-ichi Mochizuki, Shinichi MOCHIZUKI, Shinichi Mochizuki

30

Publications

4.5K

Citations

16

H-Index

46

Concepts

All Affiliations

Megmilk Snow Brand (Japan)National Defense Medical College Showa University

SM

About

Shin-ichi Mochizuki is an author at Megmilk Snow Brand (Japan) specializing in medicine, osteoporosis, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	4.4K
2	Cell Biology	10	10	3.3K
3	Health Sciences	3	3	1.5K
4	Engineering	1	1	24
5	Public Health	1	1	22

Shin-ichi Mochizuki

×

17

Publications

4.5K

Citations

16

H-Index

	Year	Citations
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup> Hisataka Yasuda, Nobuyuki Shima, N. Nakagawa, Endocrinology SclerostinImmunologyCell DeathOsteogenesisHuman Ocif	1998	1.2K
Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis Masaaki Goto, Shin-ichi Mochizuki, Kazuki Yano, Biochemical and Biophysical Research Communications InflammationSclerostinBone Morphogenic ProteinImmunologySpecifically Inhibits Osteoclastogenesis	1997	788
Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin Atsuko Mizuno, Norio Amizuka, Kazuharu Irie, Biochemical and Biophysical Research Communications Severe OsteoporosisPathologyMedicineOsteoporosisOsteocalcin	1998	771
Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-602 Hisataka Yasuda, N. Shima, N. Nakagawa, OsteogenesisBone HomeostasisSystems BiologyMedicineCell Biology	1998	652
A novel molecular mechanism modulating osteoclast differentiation and function Hisataka Yasuda, N. Shima, N. Nakagawa, Bone Novel Molecular MechanismOsteoarthritisBone HomeostasisMedicineCell Biology	1999	264
Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone Katsuyoshi Tsukii, Nobuyuki Shima, Shin-ichi Mochizuki, Biochemical and Biophysical Research Communications Prostaglandin E2Essential SignalPhysiologyParathyroid HormoneBone Homeostasis	1998	239
Osteoclastogenesis Inhibitory Factor Suppresses Osteoclast Survival by Interfering in the Interaction of Stromal Cells with Osteoclast Takuhiko Akatsu, Takehiko Murakami, Miyuki Nishikawa, Biochemical and Biophysical Research Communications Stromal CellsSclerostinDevelopmental BiologyBone Morphogenic ProteinOsteoarthritis	1998	124
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy Takuhiko Akatsu, Takehiko Murakami, Kohei Ono, Bone Bone Morphogenic ProteinNormal MiceCell DeathBone MetabolismPathology	1998	88
Characterization of Monomeric and Homodimeric Forms of Osteoclastogenesis Inhibitory Factor Akihiro Tomoyasu, Masaaki Goto, Nobuaki Fujise, Biochemical and Biophysical Research Communications Developmental BiologyHomodimeric FormsBone HomeostasisMedicineCell Biology	1998	84
Basic Fibroblast Growth Factor Induces Osteoclast Formation by Reciprocally Regulating the Production of Osteoclast Differentiation Factor and Osteoclastogenesis Inhibitory Factor in Mouse Osteoblastic Cells N. Nakagawa, Hisataka Yasuda, Kazuki Yano, Biochemical and Biophysical Research Communications Developmental BiologyBone Morphogenic ProteinFibroblast Growth FactorCell BiologyOsteoclastogenesis Inhibitory Factor	1999	63

Page 1